LON:BIOG The Biotech Growth Trust (BIOG) Share Price, News & Analysis → Urgent Nvidia Warning (From Altimetry) (Ad) Free BIOG Stock Alerts GBX 1,006 +35.00 (+3.60%) (As of 05/2/2024 ET) Add Compare Share Share Today's Range 965.88▼ 1,00650-Day Range 925▼ 1,01052-Week Range 715▼ 1,034Volume119,365 shsAverage Volume62,418 shsMarket Capitalization£346.06 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades Get The Biotech Growth Trust alerts: Email Address Ad Stansberry ResearchGold ManiaFormer Goldman VP Reveals Mysterious "Gold Bank" With Huge Upside Potential He says the gains in this should be far greater than just bullion or mining stocks. Some folks had the chance to see 995% the last time we shared this exact "bank". Most people know nothing about it (except the rich and elite).See his free reveal right here. About The Biotech Growth Trust Stock (LON:BIOG)The Biotech Growth Trust PLC is a closed ended equity mutual fund launched by Frostrow Capital LLP. It is co-managed by OrbiMed Capital LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the biotechnology sector. The fund invests in stocks of companies across all market capitalizations. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index. It was previously known as Finsbury Emerging Biotechnology Trust PLC. The Biotech Growth Trust PLC was formed on May 20, 1997 and is domiciled in the United Kingdom.Read More BIOG Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BIOG Stock News HeadlinesMay 1, 2024 | uk.finance.yahoo.comThe Biotech Growth Trust Plc - Total Voting RightsApril 25, 2024 | americanbankingnews.comThe Biotech Growth Trust (LON:BIOG) Stock Crosses Below 50-Day Moving Average of $970.73May 2, 2024 | Altimetry (Ad)Urgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.April 15, 2024 | msn.comBiotech startup raises $100 million to tackle agricultural problem using fungi: 'There's so much we don't know about this incredible group of organisms'April 11, 2024 | markets.businessinsider.comBIOR Biotech has launched the world's first technology capable of affordably and continuously cultivating soil microorganisms.April 10, 2024 | msn.com3 High-Growth Biotech Stocks Investors Should Pay Attention to in AprilApril 8, 2024 | markets.businessinsider.comBuy Rating Affirmed for Legend Biotech Following FDA Approval and Positive Growth OutlookApril 5, 2024 | msn.comRevolutionising agriculture: Here's how biotechnology is changing farming practicesMay 2, 2024 | Altimetry (Ad)Urgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.April 5, 2024 | msn.com‘Biotech Beach’: What’s behind San Diego’s biotech gold rushApril 1, 2024 | markets.businessinsider.comUnveiling 9 Analyst Insights On Legend BiotechMarch 28, 2024 | msn.comHow Sleeper Biotech Solid Biosciences, With A 687% Gain, Is Making A ComebackMarch 19, 2024 | seekingalpha.com3 Potential Biotech Buyout Targets In 2024March 10, 2024 | msn.comINTERNATIONAL BIOTECHNOLOGY TRUST: Bear market is over say managers backing growth with incomeFebruary 28, 2024 | msn.comBiotech corn marks 20 years in PHFebruary 26, 2024 | msn.comBiotech Stocks Madrigal, Altimmune In A Tizzy As New Weight-Loss Rival Enters The ArenaFebruary 22, 2024 | msn.comBiotech Company Leaving Framingham Headquarters For WalthamFebruary 19, 2024 | uk.finance.yahoo.comThe Biotech Growth Trust Plc - Net Asset Value(s)February 19, 2024 | msn.com3 Revolutionary Biotech Stocks Poised for 10X SurgeFebruary 13, 2024 | markets.businessinsider.comGet Rich Quick With These 3 Biotech Stocks to Buy NowFebruary 13, 2024 | msn.comStrength Seen in Puma Biotech (PBYI): Can Its 10.0% Jump Turn into More Strength?February 13, 2024 | msn.comThe 3 Best Biotech Stocks to Buy in February 2024February 8, 2024 | forbes.com6 Predictions For Healthcare And Biotech In 2024February 7, 2024 | realmoney.thestreet.comIs This Low-Priced Biotech Stock a Hidden Gem?February 7, 2024 | news.yahoo.comBiotech firm I-Mab to divest China operations, shift focus to USFebruary 7, 2024 | msn.com3 Biotech Stocks to Buy on the Dip: February 2024January 30, 2024 | msn.comArsenal Yards. Fenway. Waltham. These are the new hotspots for Boston biotech.See More Headlines Receive BIOG Stock News and Ratings via Email Sign-up to receive the latest news and ratings for The Biotech Growth Trust and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorFinancial Services Industry Asset Management Sub-IndustryN/A Current SymbolLON:BIOG CUSIPN/A CIKN/A Webwww.biotechgt.com Phone+44-20-74264000FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (2.30) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-92,030,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-25.77% Return on Assets-15.12% Debt Debt-to-Equity Ratio3.90 Current Ratio0.30 Quick Ratio0.00 Sales & Book Value Annual Sales£-87,660,000.00 Price / Sales-3.95 Cash FlowGBX 11.47 per share Price / Cash Flow87.74 Book ValueGBX 818 per share Price / Book1.23Miscellaneous Outstanding Shares34,400,000Free FloatN/AMarket Cap£346.06 million OptionableNot Optionable Beta0.51 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Samuel David Isaly (Age 79)Portfolio Manager Key CompetitorsInvesco Bond Income PlusLON:BIPSGresham House Energy StorageLON:GRIDHenderson International Income TrustLON:HINTLowland InvestmentLON:LWIJPMorgan Asia Growth & IncomeLON:JAGIView All CompetitorsInsidersRoger YatesBought 5,000 shares on 3/14/2024Total: £4.85 M ($969.00/share)Hamish BaillieBought 3,000 shares on 3/12/2024Total: £2.93 M ($975.00/share)Nicola ShepherdBought 1,000 shares on 2/28/2024Total: £1.00 M ($1,001.00/share)Nicola ShepherdBought 1,000 shares on 8/11/2023Total: £780,000.00 ($780.00/share)View All Insider Transactions BIOG Stock Analysis - Frequently Asked Questions How have BIOG shares performed in 2024? The Biotech Growth Trust's stock was trading at GBX 894 at the beginning of the year. Since then, BIOG stock has increased by 12.5% and is now trading at GBX 1,006. View the best growth stocks for 2024 here. What other stocks do shareholders of The Biotech Growth Trust own? Based on aggregate information from My MarketBeat watchlists, some companies that other The Biotech Growth Trust investors own include Solid Biosciences (SLDB), European Metals (EMH), Advanced Medical Solutions Group (AMS), National Grid (NG), Paysafe Group (PAYS), Polar Capital Technology Trust (PCT), Verona Pharma plc (VRP.L) (VRP), Fidelity China Special (FCSS), abrdn Asia Focus (AAS) and CVS Group (CVSG). How do I buy shares of The Biotech Growth Trust? Shares of BIOG stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:BIOG) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersUrgent Nvidia WarningAltimetryA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsTruth about Trump you’ve never heardPorter & CompanyHe Is Giving Away BitcoinCrypto Swap ProfitsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithAI “wealth window” is closing June 25thParadigm Press4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Biotech Growth Trust PLC Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
